Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Bridging Integrator 2 (BIN2) (Middle Region) Peptide

BIN2 Reactivité: Humain Hôte: Synthetic BP
N° du produit ABIN8095699
168,15 €
Plus frais de livraison 40,00 € et TVA
100 μg
Destination: France
Envoi sous 6 à 9 jours ouvrables

Aperçu rapide pour Bridging Integrator 2 (BIN2) (Middle Region) Peptide (ABIN8095699)

Antigène

BIN2 (Bridging Integrator 2 (BIN2))

Origine

Humain

Source

  • 6
Synthetic

Application

Blocking Peptide (BP)
  • Protein Region

    Middle Region

    Fonction

    BIN2 Peptide - middle region

    Séquence

    LEVSPNPEPP EKPVRTPEAK ENENIHNQNP EELCTSPTLM TSQVASEPGE
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Commentaires

    This is a synthetic peptide designed for use in combination with anti- BIN2 Antibody (ARP81374_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Buffer

    Lyophilized powder

    Stock

    -20 °C

    Stockage commentaire

    For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
  • Antigène

    BIN2 (Bridging Integrator 2 (BIN2))

    Sujet

    Background Information: Promotes cell motility and migration, probably via its interaction with the cell membrane and with podosome proteins that mediate interaction with the cytoskeleton. Modulates membrane curvature and mediates membrane tubulation. Plays a role in podosome formation. Inhibits phagocytosis.

    Alternative Symbols: BRAP-1

    Poids moléculaire

    62 kDa

    ID gène

    51411

    NCBI Accession

    NP_001276936

    UniProt

    Q9UBW5
Vous êtes ici:
Chat with us!